The Therapeutic Goods Administration (TGA) has recently updated the public information on its website about breast implant associated anaplastic large cell lymphoma in consultation with other international regulatory agencies, scientific experts including plastic surgeons, breast surgeons, haematologists, and epidemiologists as well as breast implant manufacturers.
We have known about this disease for quite some time and the TGA has been providing updates since 2011. This most recent update gives a more completed picture of our current understanding of this disease. (more…)
Posted: January 18th, 2017
Posted In: TGA Alerts